AlphaFold3与实验结构对比:对联结G蛋白结合受体中的准确性进行评估
Xin-Heng He1,2, Jun-Rui Li1, Shi-Yi Shen1,2
1State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
Acta pharmacologica Sinica
|December 6, 2024
概括
AlphaFold3 改善了 G 蛋白结合受体 (GPCR) 结构预测,但难以准确的连接体结合姿势. 实验验证对于药物设计和功能研究至关重要.
科学领域:
- 结构生物学 结构生物学
- 计算生物学 计算生物学
- 药理学 药理学 是一个学科.
背景情况:
- G蛋白结合受体 (GPCR) 是关键的药物标,但它们的复杂结构往往很难通过实验来确定.
- 预测建模为理解GPCR提供了一个有前途的途径,AlphaFold3代表了显著的进步.
研究的目的:
- 系统地评估 AlphaFold3 预测的 GPCR 结构的准确性,重点关注联结状态.
- 为了比较AlphaFold3与AlphaFold2的性能以及用于GPCR结构预测的实验数据.
主要方法:
- 对AlphaFold3预测的GPCR结构与实验确定结构进行比较分析.
- 评估各种类型 (离子,,蛋白质) 的预测准确性.
- 量化结合口袋几何和连接体方向的偏差.
主要成果:
- 与AlphaFold2.2相比,AlphaFold3证明了GPCR骨干架构的预测能力得到了改进.
- 在预测的结合联体,包括离子,和蛋白质的姿势中观察到显著的差异.
- 在高分辨率准确建模配体-GPCR相互作用方面仍然存在挑战.
结论:
- 虽然AlphaFold3增强了GPCR结构预测,但其在建模带结合姿势方面的局限性限制了其在药物设计中的直接实用性.
- 实验性结构确定对于功能研究和准确的基于结构的药物设计至关重要.
- 计算模型的进一步改进是必要的,以改善蛋白质-连接体相互作用的预测.
更多相关视频
相关概念视频
The Equilibrium Binding Constant and Binding Strength
12.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.8K
Ligand Binding Sites
12.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.7K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Transducer Mechanism: G Protein–Coupled Receptors
1.8K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.8K


